American Journal of Nuclear Medicine and Molecular Imaging

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

American Journal of Nuclear Medicine and Molecular Imaging is a journal published by Springer Science+Business Media in United States. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
2160-8407
Country
United States
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • PUBMED · 2011-08-01
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

96

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

8

i10-index

3

From OpenAlex open data (CC0).

Editorial & policy4
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
63%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Identity & continuity3
Alternate titles
Am j nucl med mol imagingAm J Nucl Med Mol ImagingAJNMMI
Source type
journal
NLM unique ID (PubMed)
101564121
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
Show all subjects (75)
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Radiomics and Machine Learning in Medical Imaging
  • Radiomics and Machine Learning in Medical Imaging
  • Peptidase Inhibition and Analysis
  • Cardiac Imaging and Diagnostics
  • Chemical Reactions and Isotopes
  • Prostate Cancer Diagnosis and Treatment
  • Neuroendocrine Tumor Research Advances
  • Radiomics and Machine Learning in Medical Imaging
  • Protease and Inhibitor Mechanisms
  • Protease and Inhibitor Mechanisms
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Lymphoma Diagnosis and Treatment
  • Alzheimer's disease research and treatments
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • HER2/EGFR in Cancer Research
  • Receptor Mechanisms and Signaling
  • Advanced MRI Techniques and Applications
  • Neuroscience and Neuropharmacology Research
  • Dementia and Cognitive Impairment Research
  • Artificial Intelligence in Healthcare and Education
  • Prostate Cancer Diagnosis and Treatment
  • Advanced MRI Techniques and Applications
  • Prostate Cancer Diagnosis and Treatment
  • Neuroscience and Neuropharmacology Research
  • Receptor Mechanisms and Signaling
  • HER2/EGFR in Cancer Research
  • Cancer Immunotherapy and Biomarkers
  • Alzheimer's disease research and treatments
  • Epilepsy research and treatment
  • Glioma Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment
  • Neuroendocrine Tumor Research Advances
  • Chemokine receptors and signaling
  • Cancer, Hypoxia, and Metabolism
  • Chemokine receptors and signaling
  • Neuroendocrine Tumor Research Advances
  • Ovarian cancer diagnosis and treatment
  • Lung Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Epilepsy research and treatment
  • Alzheimer's disease research and treatments
  • Hematological disorders and diagnostics
  • Advanced MRI Techniques and Applications
  • Head and Neck Cancer Studies
  • Lymphoma Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Radiation Therapy and Dosimetry
  • Clinical Laboratory Practices and Quality Control
  • Lung Cancer Diagnosis and Treatment
  • Endometrial and Cervical Cancer Treatments
  • Neuroscience and Neuropharmacology Research
  • Lung Cancer Treatments and Mutations
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Prostate Cancer Treatment and Research
  • Renal cell carcinoma treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: